Altimmune (ALT) – Hot Corp. News
-
Altimmune (ALT) Announces Positive Topline Results from MOMENTUM 48-Week Phase 2 Obesity Trial of Pemvidutide
-
Altimmune (ALT) is discontinuing further development of AdCOVID
-
-
-
Back to ALT Stock Lookup